Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gottlieb Wants His US FDA Team To Stay Together After He Departs

Executive Summary

Outgoing US FDA Commissioner Scott Gottlieb doesn't want a staff shakeup at the agency upon his departure. A look at near-term leadership strategies. Also, the wait time for confirmed commissioners has been trending down.

You may also be interested in...



US FDA Again Looks Outside Generic Drugs Office For New Director

Sally Choe, who has been working in the Office of Translational Sciences, will take over for Kathleen Uhl in March.

Commissioner Succession Plan? Abernethy As Gottlieb’s Number Two Offers One Option

Gottlieb’s choice of Amy Abernethy as US FDA principal deputy could set her up to succeed him, should the need arise. CDER’s Cavazzoni will fill the post on temporary basis, elevating her profile within agency.

US FDA's Ostroff, Twice An Acting Commissioner, Retiring Next Year

A former Walmart executive will replace the deputy commissioner for foods and veterinary medicine, who spent nearly 15 months total as acting commissioner.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT124751

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel